These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 7689847)
1. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847 [TBL] [Abstract][Full Text] [Related]
2. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421 [TBL] [Abstract][Full Text] [Related]
3. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals. Moukrim Z; Achour A Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):439-44. PubMed ID: 7580839 [TBL] [Abstract][Full Text] [Related]
5. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313 [TBL] [Abstract][Full Text] [Related]
6. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes. Kundu SK; Merigan TC AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446 [TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection. Borghan MA; Oka S; Takiguchi M Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326 [TBL] [Abstract][Full Text] [Related]
8. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523 [TBL] [Abstract][Full Text] [Related]
9. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual. Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428 [TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro. Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406 [TBL] [Abstract][Full Text] [Related]
14. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. Fishwild DM; Benike CJ; Engleman EG J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276 [TBL] [Abstract][Full Text] [Related]
15. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Meyerhans A; Dadaglio G; Vartanian JP; Langlade-Demoyen P; Frank R; Asjö B; Plata F; Wain-Hobson S Eur J Immunol; 1991 Oct; 21(10):2637-40. PubMed ID: 1717289 [TBL] [Abstract][Full Text] [Related]
16. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560 [TBL] [Abstract][Full Text] [Related]
17. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. Hoffenbach A; Langlade-Demoyen P; Dadaglio G; Vilmer E; Michel F; Mayaud C; Autran B; Plata F J Immunol; 1989 Jan; 142(2):452-62. PubMed ID: 2463308 [TBL] [Abstract][Full Text] [Related]
18. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. Buseyne F; McChesney M; Porrot F; Kovarik S; Guy B; Rivière Y J Virol; 1993 Feb; 67(2):694-702. PubMed ID: 7678303 [TBL] [Abstract][Full Text] [Related]
19. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. Gotch F; McAdam SN; Allsopp CE; Gallimore A; Elvin J; Kieny MP; Hill AV; McMichael AJ; Whittle HC J Immunol; 1993 Sep; 151(6):3361-9. PubMed ID: 7690804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]